Drug Pricing Archives

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

// Biotech and Pharma Therapeutics Kyverna sets plans for IPO in test of biotech enthusiasm January 17, 2024 / Kyverna / IPO / Startup More than two years after the bottom fell out for biotech stocks, the market for IPOs...

January 19, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

// Biotech and Pharma Therapeutics CRISPR pioneer Doudna allies with Danaher for gene editing center targeting rare disease and beyond January 9, 2024 / Jennifer Doudna / CRISPR / Danaher / Gene Editing CRISPR pioneer Jennifer Doudna, Ph.D., looks set...

January 12, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: January 4, 2024

// Biotech and Pharma Therapeutics AI is ‘not a panacea’ for all drug discovery challenges, but partnerships can be for Generate January 4, 2024 / Generate Biomedicines / AI / Drug Discovery / Machine Learning The geniuses of biotech—the Mozarts...

January 5, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 29, 2023

// Biotech and Pharma Therapeutics How Merck extended its monopoly on a blockbuster diabetes drug December 23, 2023 / Merk / Diabetes / Regulators Merck’s monopoly on a blockbuster diabetes drug that has generated about $50 billion in global sales...

December 29, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 15, 2023

// Biotech and Pharma Therapeutics Pfizer to deepen cost cuts as latest sales forecasts miss expectations December 13, 2023 / Pfizer / Wall Street / Cost Cutting Pfizer on Wednesday upped the target for its cost-cutting program, revealing the additional...

December 15, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: December 8, 2023

// Biotech and Pharma Therapeutics EyePoint sees stock surge on AMD drug trial data December 4, 2023 / Eyepoint / Drug Trial Data / Mid-stage Study / Eye Disease EyePoint’s medicine, called vorolanib, matched the performance of Regeneron’s top-selling drug...

December 8, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 17, 2023

// Biotech and Pharma Therapeutics Mural Oncology wants to paint a new picture in IL-2 after Alkermes spinout November 15, 2023 / Alkermes / Spinoff / Interleukin-2 / Solid Tumor Mural Oncology, Alkermes’ cancer spinoff, has officially landed with $275...

November 17, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 22, 2023

// Biotech and Pharma Therapeutics Roche’s Genentech bets on radiopharmaceuticals in partnership with PeptiDream September 20, 2023 / Roche / PeptiDream / Cancer / Bristol Myers Interest in radiopharmaceuticals has been taking off ever since Novartis won drug approval of...

September 22, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 8, 2023

September 8, 2023

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 4, 2023

// Biotech and Pharma Therapeutics Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar October 4, 2023 / Boehringer Ingelheim / Humira / AbbVie / Biosimilars After debuting its branded Humira biosim Cyltezo in July, Boehringer has launched...

August 4, 2023

1 2 3 … 6 7

Tag: Drug Pricing

Healthcare Industry News Weekly Wrap-Up: January 19, 2024

Healthcare Industry News Weekly Wrap-Up: January 12, 2024

Healthcare Industry News Weekly Wrap-Up: January 4, 2024

Healthcare Industry News Weekly Wrap-Up: December 29, 2023

Healthcare Industry News Weekly Wrap-Up: December 15, 2023

Healthcare Industry News Weekly Wrap-Up: December 8, 2023

Healthcare Industry News Weekly Wrap-Up: November 17, 2023

Healthcare Industry News Weekly Wrap-Up: September 22, 2023

Healthcare Industry News Weekly Wrap-Up: September 8, 2023

Healthcare Industry News Weekly Wrap-Up: August 4, 2023

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Drug Pricing

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺